Across |
3. | Nicotinic acid commonly causes this adverse reaction |
4. | These medications cause the greatest lowering of LDL |
6. | Mevacor is a member of this class of medications |
7. | Lowest dosed tablet available of Zocor |
8. | Vytorin is a combination of simvastatin and this medication |
11. | The number of weeks between monitoring for patients initially |
12. | Main monitoring tool for lipids. |
14. | Choestyramine is considered a bile acid ____ |
16. | Statins inhibit this enzyme |
17. | Ideally, should be <200mg/dl for an average person |
19. | Nicotinic acid ER |
21. | Gemfibrozil brand name |
22. | Reduction in CHD rates and increase in HDL is possible with light use of this |
26. | These are produced by macrophages |
27. | Ideally, should be <100mg/dl for an average person |
28. | If a fasting lipid panel is normal, screening is repeated after ____ years. |
29. | Adverse effect to monitor for with statins |
33. | Refers to any lipid disorder |
34. | These types of fats are welcomed with dyslipidemia |
36. | Elevation in blood concentration of a lipid such as cholesterol or triglyceride. |
43. | Cholesterol Inhibitor |
44. | Majority of diet for maintaining normal cholesterol should come from this |
46. | Diabetics could potentially experience this with niacin |
47. | Lipid disorders are classified as |
50. | Elderly patients may experience this adverse effect when taking a bile acid sequestrant |
51. | This supplement can reduce TGs up to 30-60% |
52. | This type of fiber is good for lowering LDL |
53. | Brand name of Rosuvastatin |
54. | Brand name of Colesevelam |
55. | An HDL > or = to this number counts as a negative risk factor. |
56. | Major non lipid risk factor for CHD |